img

Global Mucopolysaccharidosis Treatment Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Mucopolysaccharidosis Treatment Market Insights, Forecast to 2034

MPS, also known as mucopolysaccharidosis, refers to a group of key rare metabolic disorders which is caused by the absence, deficiency or malfunctioning of lysosomal enzymes called glycosaminoglycan (GAGs).
Market Analysis and InsightsGlobal Mucopolysaccharidosis Treatment Market
Global Mucopolysaccharidosis Treatment market is expected to reach to US$ 2503 million in 2024, with a positive growth of %, compared with US$ 2381 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Mucopolysaccharidosis Treatment industry is evaluated to reach US$ 3392.8 million in 2029. The CAGR will be 5.2% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Mucopolysaccharidosis Treatment market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Mucopolysaccharidosis Treatment market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Shire (Takeda Pharmaceutical Company Limited)
Denali Therapeutics
ArmaGen
REGENXBIO Inc.
Sangamo Therapeutics
BioMarin
Lysogene
Abeona Therapeutics Inc.
Ultragenyx Pharmaceutical
Genzyme Corporation
Segment by Type
Intravenous
Intracerebroventricular (ICV)

Segment by Application


Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Mucopolysaccharidosis Treatment introduction, etc. Mucopolysaccharidosis Treatment Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Mucopolysaccharidosis Treatment
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mucopolysaccharidosis Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Intravenous
1.2.3 Intracerebroventricular (ICV)
1.3 Market by Application
1.3.1 Global Mucopolysaccharidosis Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Mucopolysaccharidosis Treatment Market Perspective (2018-2029)
2.2 Global Mucopolysaccharidosis Treatment Growth Trends by Region
2.2.1 Mucopolysaccharidosis Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Mucopolysaccharidosis Treatment Historic Market Size by Region (2018-2024)
2.2.3 Mucopolysaccharidosis Treatment Forecasted Market Size by Region (2024-2029)
2.3 Mucopolysaccharidosis Treatment Market Dynamics
2.3.1 Mucopolysaccharidosis Treatment Industry Trends
2.3.2 Mucopolysaccharidosis Treatment Market Drivers
2.3.3 Mucopolysaccharidosis Treatment Market Challenges
2.3.4 Mucopolysaccharidosis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Mucopolysaccharidosis Treatment by Players
3.1.1 Global Mucopolysaccharidosis Treatment Revenue by Players (2018-2024)
3.1.2 Global Mucopolysaccharidosis Treatment Revenue Market Share by Players (2018-2024)
3.2 Global Mucopolysaccharidosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Mucopolysaccharidosis Treatment, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Mucopolysaccharidosis Treatment Market Concentration Ratio
3.4.1 Global Mucopolysaccharidosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mucopolysaccharidosis Treatment Revenue in 2022
3.5 Global Key Players of Mucopolysaccharidosis Treatment Head office and Area Served
3.6 Global Key Players of Mucopolysaccharidosis Treatment, Product and Application
3.7 Global Key Players of Mucopolysaccharidosis Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Mucopolysaccharidosis Treatment Breakdown Data by Type
4.1 Global Mucopolysaccharidosis Treatment Historic Market Size by Type (2018-2024)
4.2 Global Mucopolysaccharidosis Treatment Forecasted Market Size by Type (2024-2029)
5 Mucopolysaccharidosis Treatment Breakdown Data by Application
5.1 Global Mucopolysaccharidosis Treatment Historic Market Size by Application (2018-2024)
5.2 Global Mucopolysaccharidosis Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Mucopolysaccharidosis Treatment Market Size (2018-2029)
6.2 North America Mucopolysaccharidosis Treatment Market Size by Type
6.2.1 North America Mucopolysaccharidosis Treatment Market Size by Type (2018-2024)
6.2.2 North America Mucopolysaccharidosis Treatment Market Size by Type (2024-2029)
6.2.3 North America Mucopolysaccharidosis Treatment Market Share by Type (2018-2029)
6.3 North America Mucopolysaccharidosis Treatment Market Size by Application
6.3.1 North America Mucopolysaccharidosis Treatment Market Size by Application (2018-2024)
6.3.2 North America Mucopolysaccharidosis Treatment Market Size by Application (2024-2029)
6.3.3 North America Mucopolysaccharidosis Treatment Market Share by Application (2018-2029)
6.4 North America Mucopolysaccharidosis Treatment Market Size by Country
6.4.1 North America Mucopolysaccharidosis Treatment Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Mucopolysaccharidosis Treatment Market Size by Country (2018-2024)
6.4.3 North America Mucopolysaccharidosis Treatment Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Mucopolysaccharidosis Treatment Market Size (2018-2029)
7.2 Europe Mucopolysaccharidosis Treatment Market Size by Type
7.2.1 Europe Mucopolysaccharidosis Treatment Market Size by Type (2018-2024)
7.2.2 Europe Mucopolysaccharidosis Treatment Market Size by Type (2024-2029)
7.2.3 Europe Mucopolysaccharidosis Treatment Market Share by Type (2018-2029)
7.3 Europe Mucopolysaccharidosis Treatment Market Size by Application
7.3.1 Europe Mucopolysaccharidosis Treatment Market Size by Application (2018-2024)
7.3.2 Europe Mucopolysaccharidosis Treatment Market Size by Application (2024-2029)
7.3.3 Europe Mucopolysaccharidosis Treatment Market Share by Application (2018-2029)
7.4 Europe Mucopolysaccharidosis Treatment Market Size by Country
7.4.1 Europe Mucopolysaccharidosis Treatment Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Mucopolysaccharidosis Treatment Market Size by Country (2018-2024)
7.4.3 Europe Mucopolysaccharidosis Treatment Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Mucopolysaccharidosis Treatment Market Size (2018-2029)
8.2 China Mucopolysaccharidosis Treatment Market Size by Type
8.2.1 China Mucopolysaccharidosis Treatment Market Size by Type (2018-2024)
8.2.2 China Mucopolysaccharidosis Treatment Market Size by Type (2024-2029)
8.2.3 China Mucopolysaccharidosis Treatment Market Share by Type (2018-2029)
8.3 China Mucopolysaccharidosis Treatment Market Size by Application
8.3.1 China Mucopolysaccharidosis Treatment Market Size by Application (2018-2024)
8.3.2 China Mucopolysaccharidosis Treatment Market Size by Application (2024-2029)
8.3.3 China Mucopolysaccharidosis Treatment Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Mucopolysaccharidosis Treatment Market Size (2018-2029)
9.2 Asia Mucopolysaccharidosis Treatment Market Size by Type
9.2.1 Asia Mucopolysaccharidosis Treatment Market Size by Type (2018-2024)
9.2.2 Asia Mucopolysaccharidosis Treatment Market Size by Type (2024-2029)
9.2.3 Asia Mucopolysaccharidosis Treatment Market Share by Type (2018-2029)
9.3 Asia Mucopolysaccharidosis Treatment Market Size by Application
9.3.1 Asia Mucopolysaccharidosis Treatment Market Size by Application (2018-2024)
9.3.2 Asia Mucopolysaccharidosis Treatment Market Size by Application (2024-2029)
9.3.3 Asia Mucopolysaccharidosis Treatment Market Share by Application (2018-2029)
9.4 Asia Mucopolysaccharidosis Treatment Market Size by Region
9.4.1 Asia Mucopolysaccharidosis Treatment Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Mucopolysaccharidosis Treatment Market Size by Region (2018-2024)
9.4.3 Asia Mucopolysaccharidosis Treatment Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Mucopolysaccharidosis Treatment Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Mucopolysaccharidosis Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Mucopolysaccharidosis Treatment Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Mucopolysaccharidosis Treatment Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Mucopolysaccharidosis Treatment Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Mucopolysaccharidosis Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Mucopolysaccharidosis Treatment Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Mucopolysaccharidosis Treatment Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Mucopolysaccharidosis Treatment Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Mucopolysaccharidosis Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Mucopolysaccharidosis Treatment Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Mucopolysaccharidosis Treatment Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Mucopolysaccharidosis Treatment Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Shire (Takeda Pharmaceutical Company Limited)
11.1.1 Shire (Takeda Pharmaceutical Company Limited) Company Details
11.1.2 Shire (Takeda Pharmaceutical Company Limited) Business Overview
11.1.3 Shire (Takeda Pharmaceutical Company Limited) Mucopolysaccharidosis Treatment Introduction
11.1.4 Shire (Takeda Pharmaceutical Company Limited) Revenue in Mucopolysaccharidosis Treatment Business (2018-2024)
11.1.5 Shire (Takeda Pharmaceutical Company Limited) Recent Developments
11.2 Denali Therapeutics
11.2.1 Denali Therapeutics Company Details
11.2.2 Denali Therapeutics Business Overview
11.2.3 Denali Therapeutics Mucopolysaccharidosis Treatment Introduction
11.2.4 Denali Therapeutics Revenue in Mucopolysaccharidosis Treatment Business (2018-2024)
11.2.5 Denali Therapeutics Recent Developments
11.3 ArmaGen
11.3.1 ArmaGen Company Details
11.3.2 ArmaGen Business Overview
11.3.3 ArmaGen Mucopolysaccharidosis Treatment Introduction
11.3.4 ArmaGen Revenue in Mucopolysaccharidosis Treatment Business (2018-2024)
11.3.5 ArmaGen Recent Developments
11.4 REGENXBIO Inc.
11.4.1 REGENXBIO Inc. Company Details
11.4.2 REGENXBIO Inc. Business Overview
11.4.3 REGENXBIO Inc. Mucopolysaccharidosis Treatment Introduction
11.4.4 REGENXBIO Inc. Revenue in Mucopolysaccharidosis Treatment Business (2018-2024)
11.4.5 REGENXBIO Inc. Recent Developments
11.5 Sangamo Therapeutics
11.5.1 Sangamo Therapeutics Company Details
11.5.2 Sangamo Therapeutics Business Overview
11.5.3 Sangamo Therapeutics Mucopolysaccharidosis Treatment Introduction
11.5.4 Sangamo Therapeutics Revenue in Mucopolysaccharidosis Treatment Business (2018-2024)
11.5.5 Sangamo Therapeutics Recent Developments
11.6 BioMarin
11.6.1 BioMarin Company Details
11.6.2 BioMarin Business Overview
11.6.3 BioMarin Mucopolysaccharidosis Treatment Introduction
11.6.4 BioMarin Revenue in Mucopolysaccharidosis Treatment Business (2018-2024)
11.6.5 BioMarin Recent Developments
11.7 Lysogene
11.7.1 Lysogene Company Details
11.7.2 Lysogene Business Overview
11.7.3 Lysogene Mucopolysaccharidosis Treatment Introduction
11.7.4 Lysogene Revenue in Mucopolysaccharidosis Treatment Business (2018-2024)
11.7.5 Lysogene Recent Developments
11.8 Abeona Therapeutics Inc.
11.8.1 Abeona Therapeutics Inc. Company Details
11.8.2 Abeona Therapeutics Inc. Business Overview
11.8.3 Abeona Therapeutics Inc. Mucopolysaccharidosis Treatment Introduction
11.8.4 Abeona Therapeutics Inc. Revenue in Mucopolysaccharidosis Treatment Business (2018-2024)
11.8.5 Abeona Therapeutics Inc. Recent Developments
11.9 Ultragenyx Pharmaceutical
11.9.1 Ultragenyx Pharmaceutical Company Details
11.9.2 Ultragenyx Pharmaceutical Business Overview
11.9.3 Ultragenyx Pharmaceutical Mucopolysaccharidosis Treatment Introduction
11.9.4 Ultragenyx Pharmaceutical Revenue in Mucopolysaccharidosis Treatment Business (2018-2024)
11.9.5 Ultragenyx Pharmaceutical Recent Developments
11.10 Genzyme Corporation
11.10.1 Genzyme Corporation Company Details
11.10.2 Genzyme Corporation Business Overview
11.10.3 Genzyme Corporation Mucopolysaccharidosis Treatment Introduction
11.10.4 Genzyme Corporation Revenue in Mucopolysaccharidosis Treatment Business (2018-2024)
11.10.5 Genzyme Corporation Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Mucopolysaccharidosis Treatment Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Intravenous
Table 3. Key Players of Intracerebroventricular (ICV)
Table 4. Global Mucopolysaccharidosis Treatment Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Mucopolysaccharidosis Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Mucopolysaccharidosis Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Mucopolysaccharidosis Treatment Market Share by Region (2018-2024)
Table 8. Global Mucopolysaccharidosis Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Mucopolysaccharidosis Treatment Market Share by Region (2024-2029)
Table 10. Mucopolysaccharidosis Treatment Market Trends
Table 11. Mucopolysaccharidosis Treatment Market Drivers
Table 12. Mucopolysaccharidosis Treatment Market Challenges
Table 13. Mucopolysaccharidosis Treatment Market Restraints
Table 14. Global Mucopolysaccharidosis Treatment Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Mucopolysaccharidosis Treatment Revenue Share by Players (2018-2024)
Table 16. Global Top Mucopolysaccharidosis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mucopolysaccharidosis Treatment as of 2022)
Table 17. Global Mucopolysaccharidosis Treatment Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by Mucopolysaccharidosis Treatment Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of Mucopolysaccharidosis Treatment, Headquarters and Area Served
Table 20. Global Key Players of Mucopolysaccharidosis Treatment, Product and Application
Table 21. Global Key Players of Mucopolysaccharidosis Treatment, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Mucopolysaccharidosis Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Mucopolysaccharidosis Treatment Revenue Market Share by Type (2018-2024)
Table 25. Global Mucopolysaccharidosis Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Mucopolysaccharidosis Treatment Revenue Market Share by Type (2024-2029)
Table 27. Global Mucopolysaccharidosis Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Mucopolysaccharidosis Treatment Revenue Share by Application (2018-2024)
Table 29. Global Mucopolysaccharidosis Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Mucopolysaccharidosis Treatment Revenue Share by Application (2024-2029)
Table 31. North America Mucopolysaccharidosis Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America Mucopolysaccharidosis Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Mucopolysaccharidosis Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America Mucopolysaccharidosis Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Mucopolysaccharidosis Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Mucopolysaccharidosis Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America Mucopolysaccharidosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Mucopolysaccharidosis Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe Mucopolysaccharidosis Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Mucopolysaccharidosis Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe Mucopolysaccharidosis Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Mucopolysaccharidosis Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Mucopolysaccharidosis Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe Mucopolysaccharidosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Mucopolysaccharidosis Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 46. China Mucopolysaccharidosis Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Mucopolysaccharidosis Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 48. China Mucopolysaccharidosis Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Mucopolysaccharidosis Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia Mucopolysaccharidosis Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Mucopolysaccharidosis Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia Mucopolysaccharidosis Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Mucopolysaccharidosis Treatment Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Mucopolysaccharidosis Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia Mucopolysaccharidosis Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Mucopolysaccharidosis Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Mucopolysaccharidosis Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Mucopolysaccharidosis Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Mucopolysaccharidosis Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Mucopolysaccharidosis Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Mucopolysaccharidosis Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Mucopolysaccharidosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 63. Shire (Takeda Pharmaceutical Company Limited) Company Details
Table 64. Shire (Takeda Pharmaceutical Company Limited) Business Overview
Table 65. Shire (Takeda Pharmaceutical Company Limited) Mucopolysaccharidosis Treatment Product
Table 66. Shire (Takeda Pharmaceutical Company Limited) Revenue in Mucopolysaccharidosis Treatment Business (2018-2024) & (US$ Million)
Table 67. Shire (Takeda Pharmaceutical Company Limited) Recent Developments
Table 68. Denali Therapeutics Company Details
Table 69. Denali Therapeutics Business Overview
Table 70. Denali Therapeutics Mucopolysaccharidosis Treatment Product
Table 71. Denali Therapeutics Revenue in Mucopolysaccharidosis Treatment Business (2018-2024) & (US$ Million)
Table 72. Denali Therapeutics Recent Developments
Table 73. ArmaGen Company Details
Table 74. ArmaGen Business Overview
Table 75. ArmaGen Mucopolysaccharidosis Treatment Product
Table 76. ArmaGen Revenue in Mucopolysaccharidosis Treatment Business (2018-2024) & (US$ Million)
Table 77. ArmaGen Recent Developments
Table 78. REGENXBIO Inc. Company Details
Table 79. REGENXBIO Inc. Business Overview
Table 80. REGENXBIO Inc. Mucopolysaccharidosis Treatment Product
Table 81. REGENXBIO Inc. Revenue in Mucopolysaccharidosis Treatment Business (2018-2024) & (US$ Million)
Table 82. REGENXBIO Inc. Recent Developments
Table 83. Sangamo Therapeutics Company Details
Table 84. Sangamo Therapeutics Business Overview
Table 85. Sangamo Therapeutics Mucopolysaccharidosis Treatment Product
Table 86. Sangamo Therapeutics Revenue in Mucopolysaccharidosis Treatment Business (2018-2024) & (US$ Million)
Table 87. Sangamo Therapeutics Recent Developments
Table 88. BioMarin Company Details
Table 89. BioMarin Business Overview
Table 90. BioMarin Mucopolysaccharidosis Treatment Product
Table 91. BioMarin Revenue in Mucopolysaccharidosis Treatment Business (2018-2024) & (US$ Million)
Table 92. BioMarin Recent Developments
Table 93. Lysogene Company Details
Table 94. Lysogene Business Overview
Table 95. Lysogene Mucopolysaccharidosis Treatment Product
Table 96. Lysogene Revenue in Mucopolysaccharidosis Treatment Business (2018-2024) & (US$ Million)
Table 97. Lysogene Recent Developments
Table 98. Abeona Therapeutics Inc. Company Details
Table 99. Abeona Therapeutics Inc. Business Overview
Table 100. Abeona Therapeutics Inc. Mucopolysaccharidosis Treatment Product
Table 101. Abeona Therapeutics Inc. Revenue in Mucopolysaccharidosis Treatment Business (2018-2024) & (US$ Million)
Table 102. Abeona Therapeutics Inc. Recent Developments
Table 103. Ultragenyx Pharmaceutical Company Details
Table 104. Ultragenyx Pharmaceutical Business Overview
Table 105. Ultragenyx Pharmaceutical Mucopolysaccharidosis Treatment Product
Table 106. Ultragenyx Pharmaceutical Revenue in Mucopolysaccharidosis Treatment Business (2018-2024) & (US$ Million)
Table 107. Ultragenyx Pharmaceutical Recent Developments
Table 108. Genzyme Corporation Company Details
Table 109. Genzyme Corporation Business Overview
Table 110. Genzyme Corporation Mucopolysaccharidosis Treatment Product
Table 111. Genzyme Corporation Revenue in Mucopolysaccharidosis Treatment Business (2018-2024) & (US$ Million)
Table 112. Genzyme Corporation Recent Developments
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mucopolysaccharidosis Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Mucopolysaccharidosis Treatment Market Share by Type: 2022 VS 2029
Figure 3. Intravenous Features
Figure 4. Intracerebroventricular (ICV) Features
Figure 5. Global Mucopolysaccharidosis Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Mucopolysaccharidosis Treatment Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Mucopolysaccharidosis Treatment Report Years Considered
Figure 11. Global Mucopolysaccharidosis Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Mucopolysaccharidosis Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Mucopolysaccharidosis Treatment Market Share by Region: 2022 VS 2029
Figure 14. Global Mucopolysaccharidosis Treatment Market Share by Players in 2022
Figure 15. Global Top Mucopolysaccharidosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mucopolysaccharidosis Treatment as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Mucopolysaccharidosis Treatment Revenue in 2022
Figure 17. North America Mucopolysaccharidosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Mucopolysaccharidosis Treatment Market Share by Type (2018-2029)
Figure 19. North America Mucopolysaccharidosis Treatment Market Share by Application (2018-2029)
Figure 20. North America Mucopolysaccharidosis Treatment Market Share by Country (2018-2029)
Figure 21. United States Mucopolysaccharidosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Mucopolysaccharidosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Mucopolysaccharidosis Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Mucopolysaccharidosis Treatment Market Share by Type (2018-2029)
Figure 25. Europe Mucopolysaccharidosis Treatment Market Share by Application (2018-2029)
Figure 26. Europe Mucopolysaccharidosis Treatment Market Share by Country (2018-2029)
Figure 27. Germany Mucopolysaccharidosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Mucopolysaccharidosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Mucopolysaccharidosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Mucopolysaccharidosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Mucopolysaccharidosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Mucopolysaccharidosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Mucopolysaccharidosis Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Mucopolysaccharidosis Treatment Market Share by Type (2018-2029)
Figure 35. China Mucopolysaccharidosis Treatment Market Share by Application (2018-2029)
Figure 36. Asia Mucopolysaccharidosis Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Mucopolysaccharidosis Treatment Market Share by Type (2018-2029)
Figure 38. Asia Mucopolysaccharidosis Treatment Market Share by Application (2018-2029)
Figure 39. Asia Mucopolysaccharidosis Treatment Market Share by Region (2018-2029)
Figure 40. Japan Mucopolysaccharidosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Mucopolysaccharidosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Mucopolysaccharidosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Mucopolysaccharidosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Mucopolysaccharidosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Mucopolysaccharidosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Mucopolysaccharidosis Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Mucopolysaccharidosis Treatment Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Mucopolysaccharidosis Treatment Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Mucopolysaccharidosis Treatment Market Share by Country (2018-2029)
Figure 50. Brazil Mucopolysaccharidosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Mucopolysaccharidosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Mucopolysaccharidosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Mucopolysaccharidosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Mucopolysaccharidosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Mucopolysaccharidosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Shire (Takeda Pharmaceutical Company Limited) Revenue Growth Rate in Mucopolysaccharidosis Treatment Business (2018-2024)
Figure 57. Denali Therapeutics Revenue Growth Rate in Mucopolysaccharidosis Treatment Business (2018-2024)
Figure 58. ArmaGen Revenue Growth Rate in Mucopolysaccharidosis Treatment Business (2018-2024)
Figure 59. REGENXBIO Inc. Revenue Growth Rate in Mucopolysaccharidosis Treatment Business (2018-2024)
Figure 60. Sangamo Therapeutics Revenue Growth Rate in Mucopolysaccharidosis Treatment Business (2018-2024)
Figure 61. BioMarin Revenue Growth Rate in Mucopolysaccharidosis Treatment Business (2018-2024)
Figure 62. Lysogene Revenue Growth Rate in Mucopolysaccharidosis Treatment Business (2018-2024)
Figure 63. Abeona Therapeutics Inc. Revenue Growth Rate in Mucopolysaccharidosis Treatment Business (2018-2024)
Figure 64. Ultragenyx Pharmaceutical Revenue Growth Rate in Mucopolysaccharidosis Treatment Business (2018-2024)
Figure 65. Genzyme Corporation Revenue Growth Rate in Mucopolysaccharidosis Treatment Business (2018-2024)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries